Corbus Pharmaceuticals Holdings, Inc. (CRBP)
11.12
-0.34
(-2.97%)
USD |
NASDAQ |
Sep 04, 16:00
10.92
-0.20
(-1.80%)
After-Hours: 18:02
Corbus Pharmaceuticals Holdings Shareholders Equity (Quarterly) : 102.24M for June 30, 2026
Shareholders Equity (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Shareholders Equity (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | 102.24M |
| March 31, 2026 | 126.34M |
| December 31, 2025 | 147.50M |
| September 30, 2025 | 92.15M |
| June 30, 2025 | 110.99M |
| March 31, 2025 | 127.11M |
| December 31, 2024 | 142.43M |
| September 30, 2024 | 150.50M |
| June 30, 2024 | 125.54M |
| March 31, 2024 | 96.97M |
| December 31, 2023 | -6.905M |
| September 30, 2023 | 0.311M |
| June 30, 2023 | 9.521M |
| March 31, 2023 | 16.46M |
| December 31, 2022 | 32.99M |
| September 30, 2022 | 41.95M |
| June 30, 2022 | 49.47M |
| March 31, 2022 | 61.16M |
| December 31, 2021 | 69.11M |
| September 30, 2021 | 77.63M |
| June 30, 2021 | 76.96M |
| March 31, 2021 | 91.52M |
| December 31, 2020 | 45.27M |
| September 30, 2020 | 29.23M |
| June 30, 2020 | 48.41M |
| Date | Value |
|---|---|
| March 31, 2020 | 22.69M |
| December 31, 2019 | 6.158M |
| September 30, 2019 | 29.64M |
| June 30, 2019 | 47.37M |
| March 31, 2019 | 42.30M |
| December 31, 2018 | 27.52M |
| September 30, 2018 | 42.87M |
| June 30, 2018 | 55.49M |
| March 31, 2018 | 65.54M |
| December 31, 2017 | 57.78M |
| September 30, 2017 | 31.98M |
| June 30, 2017 | 37.59M |
| March 31, 2017 | 43.59M |
| December 31, 2016 | 8.919M |
| September 30, 2016 | 13.31M |
| June 30, 2016 | 17.65M |
| March 31, 2016 | 6.404M |
| December 31, 2015 | 8.985M |
| September 30, 2015 | 11.17M |
| June 30, 2015 | 6.769M |
| March 31, 2015 | 4.692M |
| December 31, 2014 | 5.863M |
| September 30, 2014 | 7.016M |
| June 30, 2014 | 7.450M |
| March 31, 2014 |
Shareholders' Equity Definition
Represents the value of Shareholders' Equity as of the close of the report date, belonging to both Preferred and Common Equity Shareholders.
Shareholders Equity (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Shareholders Equity (Quarterly) Benchmarks
| ACADIA Pharmaceuticals, Inc. | 1.307B |
| Alnylam Pharmaceuticals, Inc. | 1.354B |
| Anika Therapeutics, Inc. | 137.28M |
| Savara, Inc. | 143.66M |
| Vericel Corp. | 370.04M |
Shareholders Equity (Quarterly) Related Metrics
| Total Assets (Quarterly) | 126.99M |
| Total Liabilities (Quarterly) | 24.75M |
| Debt to Equity Ratio | 0.0417 |
| Current Ratio | 5.714 |
| Net Debt Paydown Yield | -0.16% |